Cargando…
Assessment of change in quality of life, carcinoid syndrome symptoms and healthcare resource utilization in patients with carcinoid syndrome
BACKGROUND: There is limited information on changes over time in carcinoid syndrome (CS) symptoms and quality of life (QoL). This study assessed change in CS symptoms and QoL in patients treated with somatostatin analogs (SSAs) using the Functional Assessment of Cancer Therapy-General (FACT-G) and P...
Autores principales: | Halperin, Daniel M., Huynh, Lynn, Beaumont, Jennifer L., Cai, Beilei, Bhak, Rachel H., Narkhede, Sahil, Totev, Todor, Duh, Mei S., Neary, Maureen P., Cella, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437890/ https://www.ncbi.nlm.nih.gov/pubmed/30922252 http://dx.doi.org/10.1186/s12885-019-5459-x |
Ejemplares similares
-
Impact of carcinoid syndrome symptoms and long-term use of somatostatin analogs on quality of life in patients with carcinoid syndrome: A survey study
por: Halperin, Daniel M., et al.
Publicado: (2018) -
Survival and Clinical Outcomes with Telotristat Ethyl in Patients with Carcinoid Syndrome
por: Metz, David C, et al.
Publicado: (2020) -
The Carcinoid Syndrome
por: Strahan, Jack
Publicado: (1961) -
The Carcinoid Syndrome
Publicado: (1973) -
Management of Diarrhea in Patients With Carcinoid Syndrome
por: Naraev, Boris G., et al.
Publicado: (2019)